Evidence map›Paper›PMID 41493708›Full record

ArticleProbiotics and antimicrobial proteins2026

Screening the γ-core Motif Peptides of Ascomycetous Antifungal Proteins for Antifungal Activity and Potential Therapeutic Applicability.

John K Karemera, Györgyi Váradi, Gábor Bende, Richárd Merber, Kinga Dán, Csaba Papp, Attila Farkas, Gergely Maróti, Gábor K Tóth, Attila Borics and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John K KaremeraDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.ORCID http://orcid.org/0009-0008-4316-6904
Györgyi VáradiDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.ORCID http://orcid.org/0000-0001-7907-8908
Gábor BendeDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.ORCID http://orcid.org/0000-0003-4571-9775
Richárd MerberDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.
Kinga DánDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.ORCID http://orcid.org/0009-0003-1900-6517
Csaba PappDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary.ORCID http://orcid.org/0000-0003-4450-0667
Attila FarkasInstitute of Plant Biology, HUN-REN Biological Research Centre, Szeged, Hungary.ORCID http://orcid.org/0000-0002-0413-8248
Gergely MarótiInstitute of Plant Biology, HUN-REN Biological Research Centre, Szeged, Hungary.ORCID http://orcid.org/0000-0002-3705-0461
Gábor K TóthDepartment of Medical Chemistry, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
Attila BoricsInstitute of Biochemistry, HUN-REN Biological Research Centre, Szeged, Hungary.ORCID http://orcid.org/0000-0002-6331-3536
László GalgóczyDepartment of Biotechnology and Microbiology, Faculty of Science and Informatics, University of Szeged, Szeged, Hungary. galgoczi@bio.u-szeged.hu.ORCID http://orcid.org/0000-0002-6976-8910

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of fungal infections has increased markedly in recent years, driven by increasing resistance to conventional antifungal agents. To address this challenge, the World Health Organization has highlighted the urgent need for novel antifungal molecules, particularly those that can enhance the efficacy of existing drugs. Synthetic peptides (γAFPs), derived from conserved γ-core motifs (GXC-X

Indexed as

Antifungal AgentsAscomycotaFungal ProteinsPeptidesAnimalsAspergillusAspergillus fumigatusCandida albicansMicrobial Sensitivity TestsMothsAntifungal AgentsFungal ProteinsPeptidesAntifungal peptideAspergillus fumigatusCandida albicansPeptide-drug interactionTherapeutic efficacyΓγ-core motif

Identifiers

PMID41493708
PMCPMC13369176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.